TGFB1 and atherosclerosis: However, the immunoinflammatory response in atherosclerosis is modulated by the regulatory pathways in which the two anti-inflammatory cytokines, interleukin 10 (IL-10) and transforming growth factor β (TGF-β), play a critical role.